Treatment Fees and Retention on Methadone Maintenance

Date01 July 1994
AuthorThomas J. Prihoda,David P. Desmond,James F. Maddux
DOI10.1177/002204269402400305
Published date01 July 1994
Subject MatterArticle
The Journal of Drug Issues 24(3),429-443 1994
TREATMENT FEES AND RETENTION ON METHADONE
MAINTENANCE
James F. Maddux
Thomas J. Prihoda
David P. Desmond
Several
reports
have
suggested
that
required
treatment
fees
impair
retention
on
methadone
maintenance.
In a
controlled
study,
152 illicitopioid
users
admitted
to
methadone
maintenance
were
randomly
assigned
to fee or no-
fee
status.
The
fee
subjects
were
required
to pay afee of $2.50per day and
the
no-fee
subjects
were
required
to pay
nothing.
Elimination
of fees
significantly
increased
retention.
Only
34%
of thefee
subjects
but 54% of
the
no-fee
subjects
were
retained
for one
year.
Of
those
retained
for one
year,
the fee
subjects
and the
no-fee
subjects
showed
only
small and
nonsignificant
differences
on
urine
test
results
and
measures
of
social
performance.
Interviews
per
month
with
caseworker
were
inversely
related
to
retention.
Increased
interviews
and
decreased
retention
may
both
have
reflected
treatment
problems
of
subjects.
Introduction
Since
methadone maintenance was introduced in 1965, many studies have
found that opioid users reduce their illicit opioid use and improve their social
performance while maintained on methadone (Senay 1985; Platt 1986; Woody and
O'Brien 1986; Hubbard et al. 1989; Lowinson et al. 1992). When they leave
treatment, however, most resume illicit opioid use (Dole and Joseph 1978; Ball
and Ross 1991). The effectiveness of methadone maintenance seems to depend on
continued treatment. Retention in treatment has become more urgent with the
recognition in the 1980s that the acquired immunodeficiency syndrome (AIDS) is
spread through sharing of injection equipment (Cooper 1989). Despite the
importance of retention in treatment, reported one-year retention rates among
methadone programs have varied widely (Maddux 1993), from 89% (Gearing
1974) to 34% (Hubbard et al. 1989). The sources of these widely varying rates
James
F.
Maddux.
M.D., serves as professor in the Department of Psychiatry of the University of Texas Health
Science Center at San Antonio. He is principal investigator of a NIDA-supported project to improve methadone and
has authored or co-authored over fifty published articles in the field of substance abuse.
Thomas
J.
Prihoda,
Ph.D., is an assistant professor and has been on the facully of the University of Texas Health Science Center at San
Antonio since 1982. He has been an investigator on several research projects and has authored or co-authored over
fifty publications in which he was responsible for the statistical content, David P. Desmond. M.S. W.• has served
as senior research associate and Instructor in the Department of Psychiatry of the University of Texas Health
Science Center at San Antonio since 1971. His research interests include the etiology. natural history. and treatment
of substance abuse. This article was presented in part at the annual meeting of the College on Problems of Drug
Dependence in Toronto, 14 June 1993. Send reprint requests to James F. Maddux, M.D., Department of
PSYChiatry,
UTHSCSA, 7703 Floyd Curl Drive, San Antonio TX 78284-7792.
©Journal of Drug Issues, Inc. 002-0426/94/03/429-443 $1.00
429

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT